Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Recruiting · NCT07397338 · Registry updated 2026-08-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colorectal carcinoma, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, rectal disorder, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-08-03 | NCT07397338 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Revolution Medicines, Inc. | 18 |
| Summit Therapeutics | 31 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Eastern Connecticut Hematology and Oncology Associates | Norwich | United States | 29 |
| Health Partners Cancer Center at Regions Hospital | Saint Paul | United States | 5 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| NEXT Dallas | Irving | United States | 18 |
| NEXT Oncology | San Antonio | United States | 70 |
| NEXT Virginia | Fairfax | United States | 83 |
| Tennessee Oncology | Nashville | United States | 1 |
| Usc Norris Comprehensive Cancer Center | Los Angeles | United States | 67 |